Study casts doubt on long-term bisphosphonate efficacy

More is not necessarily better in preventing hip fracture, researchers say

Long-term oral bisphosphonate therapy doesn’t seem to give women any extra protection against osteoporotic hip fracture, a new study suggests.

But there’s a hint that staying on the therapy for seven years could be the sweet spot that might spare some women from the morbidity associated with longer term use.